Alabama HB533: Public health, authorized forms of single-dose epinephrine used by public schools and authorized entities expanded

What the bill says

An Act, Relating to public health; to amend Sections 16-1-39, 16-1-48, and 22-1-16, Code of Alabama 1975, to expand the form of epinephrine approved to be carried and self-administered by students, and stocked and administered by schools, authorized entities, and certain staff members.

From the enrolled text:

An Act, Relating to public health; to amend Sections 16-1-39, 16-1-48, and 22-1-16, Code of Alabama 1975, to expand the form of epinephrine approved to be carried and self-administered by students, and stocked and administered by schools, authorized entities, and certain staff members. BE IT ENACTED BY THE LEGISLATURE OF ALABAMA: Section 1. Sections 16-1-39, 16-1-48, and 22-1-16, Code of Alabama 1975, are amended to read as follows: "§16-1-39 (a) Commencing with the 2007-2008 scholastic year, each local board of education and the governing body of each nonpublic school in the state shall permit the self-administration of medications by a student for chronic conditions if conducted in compliance with the State Department of Education and State Board of Nursing Medication Curriculum, as may be amended from time to time by the department and board. Approved medications may be self-administered if the parent or legal guardian of the student provides all of the information outlined in the medication curriculum, including, but not limited to, all of the following: (1) Written and signed authorization for the self-administration to the chief executive officer of the school. (2) Written and signed acknowledgement acknowledgment that the school shall incur no liability and that the parent Page that the school shall incur no liability and that the parent HB533 Enrolled or legal guardian shall indemnify and …

Read the full official text

Sponsors

• Wilcox, Margie (R, HD-104) · primary sponsor

Latest actions

1. April 17, 2026: Enacted
2. April 9, 2026: Delivered to Governor
3. April 9, 2026: Signature Requested
4. April 9, 2026: Enrolled
5. April 9, 2026: Ready to Enroll
6. April 8, 2026: Motion to Read a Third Time and Pass - Adopted Roll Call 1271
7. April 1, 2026: Read for the Second Time and placed on the Calendar
8. April 1, 2026: Reported Out of Committee Second House
9. March 31, 2026: Pending Committee Action in Second House
10. March 31, 2026: Read for the first time and referred to the Senate Committee on Healthcare

Votes

• Senate Roll Call #1271 (April 8, 2026): 30 yea, 0 nay, passed
• House Roll Call #966 (March 17, 2026): 105 yea, 0 nay, passed
• House Roll Call #965 (March 17, 2026): 105 yea, 0 nay, passed

Common questions

What is HB533?

HB533 is a bill in the Alabama Legislature (2026 Regular Session): Public health, authorized forms of single-dose epinephrine used by public schools and authorized entities expanded.

What does HB533 do?

In its own words: An Act, Relating to public health; to amend Sections 16-1-39, 16-1-48, and 22-1-16, Code of Alabama 1975, to expand the form of epinephrine approved to be carried and self-administered by students, and stocked and administered by schools, authorized entities, and certain staff members.

What is the status of HB533?

Signed into law as of April 17, 2026. Latest action: Enacted (April 17, 2026).

Who sponsored HB533?

Wilcox, Margie (R, HD-104).

Where is the official record for HB533?

On the Alabama Legislature website: https://alison.legislature.state.al.us/instrument/2026RS/HB533